stoxline Quote Chart Rank Option Currency Glossary
  
Roivant Sciences Ltd. (ROIV)
10.46  0.1 (0.97%)    04-19 16:00
Open: 10.3
High: 10.48
Volume: 4,323,468
  
Pre. Close: 10.36
Low: 10.265
Market Cap: 8,429(M)
Technical analysis
2024-04-19 5:12:02 PM
Short term     
Mid term     
Targets 6-month :  12.87 1-year :  13.78
Resists First :  11.02 Second :  11.8
Pivot price 11.01
Supports First :  9.76 Second :  8.12
MAs MA(5) :  10.56 MA(20) :  10.84
MA(100) :  10.71 MA(250) :  10.37
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  16.3 D(3) :  25
RSI RSI(14): 43
52-week High :  13.23 Low :  8.06
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ROIV ] has closed above bottom band by 19.6%. Bollinger Bands are 7.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 10.5 - 10.57 10.57 - 10.64
Low: 10.09 - 10.18 10.18 - 10.26
Close: 10.32 - 10.46 10.46 - 10.59
Company Description

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Headline News

Tue, 02 Apr 2024
Roivant Sciences Breaks Above 200-Day Moving Average - Bullish for ROIV - Nasdaq

Tue, 12 Mar 2024
ROIV Stock Quote Price and Forecast - CNN

Wed, 21 Feb 2024
We Believe Roivant Sciences' (NASDAQ:ROIV) Earnings Are A Poor Guide For Its Profitability - Simply Wall St

Thu, 15 Feb 2024
Do You Think the Management of Roivant Sciences (ROIV) Can Create Value? - Yahoo Finance

Tue, 13 Feb 2024
Roivant Sciences Ltd. (ROIV) Q3 2023 Earnings Call Transcript - Seeking Alpha

Sat, 10 Feb 2024
Roivant Sciences Ltd President & COO Eric Venker Sells 96950 Shares - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 806 (M)
Held by Insiders 4.2313e+008 (%)
Held by Institutions 20.6 (%)
Shares Short 27,690 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.03e+009
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 3 %
Operating Margin 624.1 %
Return on Assets (ttm) -774.2 %
Return on Equity (ttm) -13.8 %
Qtrly Rev. Growth 1.2324e+008 %
Gross Profit (p.s.) 87.91
Sales Per Share 78.95
EBITDA (p.s.) 0
Qtrly Earnings Growth 5.2 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -836 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0.13
Price to Cash Flow 1.85
Stock Dividends
Dividend 0
Forward Dividend 3.093e+007
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android